导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -29.27% | 338/354 |
| 近一周 | -3.11% | 244/356 |
| 近一月 | -6.74% | 288/362 |
| 近一季 | -6.65% | 268/362 |
| 近半年 | -19.33% | 343/358 |
| 近一年 | -35.94% | 331/349 |
| 近两年 | 3.28% | 285/314 |
| 近三年 | 2.20% | 190/244 |
| 成立以来 | -2.94% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-19.06% 345/360 |
-15.66% 350/366 |
- - |
- - |
| 2025 | 25.87% 63/358 |
22.66% 29/340 |
-3.84% 315/348 |
25.23% 34/354 |
-14.79% 267/358 |
| 2024 | 23.22% 62/329 |
-2.28% 187/280 |
9.43% 27/310 |
26.67% 72/318 |
-9.03% 271/329 |
| 2023 | -9.50% 153/275 |
4.73% 79/205 |
-9.92% 196/230 |
-2.45% 36/262 |
-1.66% 177/276 |
| 2022 | -15.95% 75/201 |
-17.92% 118/153 |
12.31% 20/164 |
-19.73% 120/189 |
13.58% 65/202 |
| 2021 | -39.80% 98/150 |
-0.95% 240/312 |
-5.34% 302/328 |
-27.10% 317/358 |
-11.92% 135/151 |
| 2020 | 39.86% 12/103 |
-3.98% 60/280 |
28.48% 52/295 |
10.74% 46/299 |
2.38% 230/305 |
| 2019 | - - |
- - |
-4.60% 242/267 |
-1.84% 181/253 |
17.55% 10/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 易方达中证海外50ETF联接人民币C VS. 建信富时100指数(QDII)人民币A(539003) |